One of Asia's Foremost Endocrinologists
Dr. Anil Bhansali is one of Asia's most distinguished endocrinologists, with a career spanning 30+ years. He served as Head of the Department of Endocrinology at PGIMER Chandigarh for 20 years β India's premier medical institution β before founding Gini Advanced Care Hospital in November 2021 to build India's most outcomes-driven endocrinology and diabetes practice.
20 years as Head of Department (1991β2021) at India's #1 medical institution
Recognised in Stanford's global scientist ranking for multiple consecutive years
India's highest honour in medicine, conferred by the President of India
Research spanning Endocrinology, Metabolic Disorders, Stem Cell Therapy, and Diabetic Foot
Led India's national endocrinology body
Research Society for Study of Diabetes in India
A standard reference textbook used in medical colleges across India
Dr. Bhansali's pioneering work on autologous stem cell transplantation in Type 2 Diabetes demonstrated significant, measurable reductions in insulin requirements β a landmark finding that influenced clinical protocols globally. This research is now central to Gini Hospital's T2D reversal programme.
His studies on metformin's effects on metabolic syndrome and real-world GLP-1 outcomes have directly shaped how Gini manages over 1,200 GLP-1 patients today. Every protocol is personalised based on his research findings and live patient outcome data.
Dr. Bhansali's clinical contributions to diabetic foot management and wound care are reflected in Gini Hospital's 95%+ limb salvage rate β among the best outcomes in North India, and dramatically above the national average of approximately 60%.
Since founding Gini Advanced Care Hospital in November 2021, Dr. Bhansali has built one of India's most rigorously tracked endocrinology and diabetes practices β with outcomes that consistently exceed national benchmarks.
All outcomes tracked in our proprietary patient database. Data available for clinical review on request.
Patients who have been told their condition is "uncontrollable" or who have failed multiple treatment regimens elsewhere often find resolution under Dr. Bhansali's care. His depth of experience with complex, multi-complication cases is unmatched in the region.
Every treatment protocol at Gini is backed by Dr. Bhansali's published research and the hospital's own proprietary patient outcome database. Decisions are made using evidence, not intuition alone. Patients receive clear explanations of why each treatment is recommended.
Dr. Bhansali's philosophy is to reverse disease where possible, not simply manage symptoms with escalating medications. At Gini, approximately 60% of diabetes patients reduce or eliminate their medications β a result rarely seen elsewhere.
Unlike larger institutions where senior doctors may delegate most patient interactions, Dr. Bhansali personally reviews all complex and inpatient cases. Patients see the senior physician, not just a registrar.
OPD: MonβSat Β· 10:00 AM β 6:00 PM Β· Gini Advanced Care Hospital, Mohali
Due to high demand, Dr. Bhansali's slots fill several weeks in advance. Book early or call us to check availability.
Dr. Anil Bhansali is one of Asia's foremost endocrinologists. He served as Head of Endocrinology at PGIMER Chandigarh for 20 years, has 400+ publications and 81,000+ Google Scholar citations, and is a BC Roy Award recipient. He is currently Medical Director and Chief Endocrinologist at Gini Advanced Care Hospital, Mohali, Punjab.
Yes. Dr. Bhansali sees patients at Gini Advanced Care Hospital, Sector 69, SAS Nagar, Mohali. OPD hours are Monday to Saturday, 10 AM to 6 PM. Book via the website or call 0172 412 0100. Due to high demand, slots book several weeks in advance.
Dr. Bhansali specialises in all endocrine and metabolic conditions including Type 1 and Type 2 Diabetes, thyroid disorders, PCOS, pituitary tumours, adrenal disorders, osteoporosis, and complex diabetic complications including diabetic foot and nephropathy. He is also known for managing difficult multi-complication inpatient cases.
In the most recent 6-month patient cohort, 80β85% of Dr. Bhansali's diabetes patients achieved HbA1c control below 7.0. The overall control rate across 4.5 years of practice is approximately 60%, significantly higher than the national average of under 20%. Triple control of sugar, blood pressure, and cholesterol is achieved in 50β70% of patients, compared to a national average of approximately 7%.